To assess the frequency of MYCN overexpression in T-ALL we analyzed the expression profiles of blast cells from 174 pediatric and adult T-ALL samples and of mononuclear cells from 74 healthy bone marrow donors from the previously reported Stage 1 MILE study [31]. This evidence concerns the gene MYCN and acute lymphoblastic leukemia.